William J. John
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 44
- Lung Cancer Research Studies 17
- Pancreatic and Hepatic Oncology Research 10
- Colorectal Cancer Treatments and Studies 9
- Peptidase Inhibition and Analysis 5
-
- Lung Cancer Treatments and Mutations 34
- Lung Cancer Diagnosis and Treatment 7
- Advanced Breast Cancer Therapies 5
- Co-authors
- Luis Paz‐Ares (17 shared papers)Eckart Laack (6 shared papers)Annamaria H. Zimmermann (12 shared papers)Patrick Peterson (8 shared papers)Carla Visseren‐Grul (12 shared papers)Nadia Chouaki (12 shared papers)Filippo de Marinis (11 shared papers)Michael Thomas (7 shared papers)
- Journals
- Journal of Clinical Oncology (13 papers)Journal of Thoracic Oncology (7 papers)Annals of Oncology (5 papers)Lung Cancer (4 papers)Clinical Lung Cancer (4 papers)
- Partner nations
- United StatesSpainGermany
In The Last Decade
William J. John
84 papers receiving 4.5k citations
William J. John's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 2.3k
- Cancer Research 463
- Immunology 378
- Molecular Biology 842
Countries citing papers authored by William J. John
This map shows the geographic impact of William J. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. John more than expected).
Fields of papers citing papers by William J. John
This network shows the impact of papers produced by William J. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. John. The network helps show where William J. John may publish in the future.
Co-authors
The 25 scholars most cited alongside William J. John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study Hit paper breakdown → | 2009 | 856 |
| 2 | Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial Hit paper breakdown → | 2012 | 457 |
| 3 | PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2013 | 456 |
| 4 | 2013 | 289 | |
| 5 | 2005 | 260 | |
| 6 | 2018 | 239 | |
| 7 | 2000 | 157 | |
| 8 | 2006 | 138 | |
| 9 | 1999 | 135 | |
| 10 | 1995 | 112 | |
| 11 | Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen. | 1997 | 103 |
| 12 | 2007 | 95 | |
| 13 | 2000 | 86 | |
| 14 | 2000 | 85 | |
| 15 | 1989 | 71 | |
| 16 | 2012 | 59 | |
| 17 | 2004 | 57 | |
| 18 | 2020 | 50 | |
| 19 | 2012 | 44 | |
| 20 | 2014 | 43 |
About William J. John
William J. John is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 86 papers that have together received 4.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Research Studies (17 papers), Pancreatic and Hepatic Oncology Research (10 papers), Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Diagnosis and Treatment (7 papers), Cancer Genomics and Diagnostics (6 papers), Peptidase Inhibition and Analysis (5 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (2.3k citations), Cancer Research (463 citations), Immunology (378 citations) and Molecular Biology (842 citations). William J. John has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Luis Paz‐Ares, Eckart Laack, Annamaria H. Zimmermann, Patrick Peterson, Carla Visseren‐Grul, Nadia Chouaki, Filippo de Marinis, Michael Thomas, Jean-Louis Pujol and Mircea Dediu. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Lung Cancer and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.